Oprozomib
Oprozomib (ONX-0912; PR-047) is a potent, orally bioavailable proteasome inhibitor that inhibits chymotrypsin-like (CT-L) activity of 20S proteasome β5/LMP7 with IC50 of 36/82 nM.
Product Specifications
CAS Number
935888-69-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
532.6092
Molecular Formula
C25H32N4O7S
Notes
Research use only, not for human use.
Receptor
20Sproteasome
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV775363 1.0 µg DNA
RPL7AP42 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details bs-12388R-PerCP-Cy5.5 100 µL
KIF7 Polyclonal Antibody, PerCP-Cy5.5 Conjugated
Sign In for Pricing
View Details 032124-FITC 200 µL
ASB17, CT (ASB17, Ankyrin repeat and SOCS box protein 17) (FITC) discontinued
Sign In for Pricing
View Details MBS2502116-01 24 Tests
Porcine MMP-10 (Matrix Metalloproteinase 10) ELISA Kit
Sign In for Pricing
View Details